Mostrar el registro sencillo del ítem
dc.contributor.author
Muntau, Ania Carolina
dc.contributor.author
Adams, Darius J.
dc.contributor.author
Bélanger Quintana, Amaya
dc.contributor.author
Bushueva, Tatiana V.
dc.contributor.author
Cerone, Roberto
dc.contributor.author
Chien, Yin Hsiu
dc.contributor.author
Chiesa, Ana Elena
dc.contributor.author
Coşkun, Turgay
dc.contributor.author
de las Heras, Javier
dc.contributor.author
Feillet, François
dc.contributor.author
Katz, Rachel
dc.contributor.author
Lagler, Florian
dc.contributor.author
Piazzon, Flavia
dc.contributor.author
Rohr, Fran
dc.contributor.author
van Spronsen, Francjan J.
dc.contributor.author
Vargas, Paula
dc.contributor.author
Wilcox, Gisela
dc.contributor.author
Bhattacharya, Kaustuv
dc.date.available
2021-02-26T19:19:37Z
dc.date.issued
2019-05
dc.identifier.citation
Muntau, Ania Carolina; Adams, Darius J.; Bélanger Quintana, Amaya; Bushueva, Tatiana V.; Cerone, Roberto; et al.; International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria; Academic Press Inc Elsevier Science; Molecular Genetics And Metabolism; 127; 1; 5-2019; 1-11
dc.identifier.issn
1096-7192
dc.identifier.uri
http://hdl.handle.net/11336/126862
dc.description.abstract
Phenylketonuria (PKU) is an inherited metabolic disease caused by phenylalanine hydroxylase (PAH) deficiency. As the resulting high blood phenylalanine (Phe) concentration can have detrimental effects on brain development and function, international guidelines recommend lifelong control of blood Phe concentration with dietary and/or medical therapy. Sapropterin dihydrochloride is a synthetic preparation of tetrahydrobiopterin (6R-BH4), the naturally occurring cofactor of PAH. It acts as a pharmacological chaperone, reducing blood Phe concentration and increasing dietary Phe tolerance in BH4-responsive patients with PAH deficiency. Protocols to establish responsiveness to sapropterin dihydrochloride vary widely. Two meetings were held with an international panel of clinical experts in PKU management to develop recommendations for sapropterin dihydrochloride response testing. At the first meeting, regional differences and similarities in testing practices were discussed based on guidelines, a literature review, outcomes of a global physician survey, and case reports. Statements developed based on the discussions were sent to all participants for consensus (>70% of participants) evaluation using a 7-level rating system, and further discussed during the second meeting. The experts recommend sapropterin dihydrochloride response testing in patients with untreated blood Phe concentrations of 360–2000 μmol/L, except in those with two null mutations. For neonates, a 24-h sapropterin dihydrochloride loading test is recommended; responsiveness is defined as a decrease in blood Phe ≥30%. For older infants, children, adolescents, and adults, a test duration of ≥48 h or a 4-week trial is recommended. The main endpoint for a 48-h to 7-day trial is a decrease in blood Phe, while improved Phe tolerance is the endpoint to be assessed during a longer trial. Longer trials may not be feasible in some locations due to lack of reimbursement for hospitalization, while a 4-week trial may not be possible due to limited access to sapropterin dihydrochloride or public health regulation. A 48-h response test should be considered in pregnant patients who cannot achieve blood Phe ≤360 μmol/L with a Phe-restricted diet. Durability of response and clinical benefits of sapropterin dihydrochloride should be assessed over the long term. Harmonization of protocols is expected to improve identification of responders and comparability of test results worldwide.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Academic Press Inc Elsevier Science
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.subject
PHENYLALANINE
dc.subject
PHENYLKETONURIA
dc.subject
PREGNANCY
dc.subject
RESPONSE
dc.subject
SAPROPTERIN DIHYDROCHLORIDE
dc.subject
TETRAHYDROBIOPTERIN
dc.subject.classification
Endocrinología y Metabolismo
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2020-11-06T20:26:15Z
dc.journal.volume
127
dc.journal.number
1
dc.journal.pagination
1-11
dc.journal.pais
Estados Unidos
dc.description.fil
Fil: Muntau, Ania Carolina. University Medical Center Hamburg Eppendorf; Alemania
dc.description.fil
Fil: Adams, Darius J.. Morristown Medical Center; Estados Unidos
dc.description.fil
Fil: Bélanger Quintana, Amaya. Hospital Ramón y Cajal; España
dc.description.fil
Fil: Bushueva, Tatiana V.. National Medical Research Center of Children's Health of the Ministry of Health of the Russian Federation; Rusia
dc.description.fil
Fil: Cerone, Roberto. Università degli Studi di Genova; Italia
dc.description.fil
Fil: Chien, Yin Hsiu. National Taiwan University Hospital; China
dc.description.fil
Fil: Chiesa, Ana Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de Endocrinología Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina
dc.description.fil
Fil: Coşkun, Turgay. Hacettepe University; Turquía
dc.description.fil
Fil: de las Heras, Javier. Universidad del País Vasco; España
dc.description.fil
Fil: Feillet, François. Children's University Hospital; Francia
dc.description.fil
Fil: Katz, Rachel. Ann and Robert Lurie Children's Hospital of Chicago; Estados Unidos
dc.description.fil
Fil: Lagler, Florian. Paracelsus Medical University; Austria
dc.description.fil
Fil: Piazzon, Flavia. Associação de Pais E Amigos Dos Excepcionais de São Paulo; Brasil
dc.description.fil
Fil: Rohr, Fran. Boston Children's Hospital; Estados Unidos
dc.description.fil
Fil: van Spronsen, Francjan J.. University of Groningen; Países Bajos
dc.description.fil
Fil: Vargas, Paula. Hospital Materno Infantil Presidente Vargas; Brasil
dc.description.fil
Fil: Wilcox, Gisela. University of Manchester; Reino Unido
dc.description.fil
Fil: Bhattacharya, Kaustuv. University of Sydney; Australia
dc.journal.title
Molecular Genetics And Metabolism
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.ymgme.2019.04.004
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S109671921930037X?via%3Dihub
Archivos asociados